MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 260 filers reported holding MYRIAD GENETICS INC in Q2 2018. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $4,443,000 | +41.0% | 145,900 | -8.4% | 0.00% | +50.0% |
| Q4 2020 | $3,151,000 | +48.8% | 159,346 | -1.8% | 0.00% | 0.0% |
| Q3 2020 | $2,117,000 | +18.5% | 162,346 | +3.0% | 0.00% | 0.0% |
| Q2 2020 | $1,787,000 | -21.2% | 157,546 | -0.6% | 0.00% | -33.3% |
| Q1 2020 | $2,267,000 | -54.0% | 158,446 | -12.5% | 0.00% | -25.0% |
| Q4 2019 | $4,933,000 | +1.0% | 181,146 | +6.2% | 0.00% | -20.0% |
| Q3 2019 | $4,884,000 | +23.3% | 170,585 | +19.6% | 0.01% | 0.0% |
| Q2 2019 | $3,962,000 | -26.1% | 142,615 | -11.6% | 0.01% | -28.6% |
| Q1 2019 | $5,358,000 | +11.9% | 161,382 | -2.0% | 0.01% | 0.0% |
| Q4 2018 | $4,787,000 | -42.4% | 164,684 | -8.9% | 0.01% | -36.4% |
| Q3 2018 | $8,315,000 | +33.6% | 180,758 | +8.5% | 0.01% | +22.2% |
| Q2 2018 | $6,224,000 | -22.5% | 166,553 | -38.8% | 0.01% | -18.2% |
| Q1 2018 | $8,035,000 | -26.6% | 271,925 | -14.7% | 0.01% | -26.7% |
| Q4 2017 | $10,943,000 | +6.0% | 318,617 | +11.7% | 0.02% | 0.0% |
| Q3 2017 | $10,321,000 | +45.2% | 285,280 | +3.7% | 0.02% | +36.4% |
| Q2 2017 | $7,106,000 | +43.5% | 275,000 | +6.6% | 0.01% | +37.5% |
| Q1 2017 | $4,952,000 | +24.0% | 257,900 | +7.7% | 0.01% | +14.3% |
| Q4 2016 | $3,992,000 | -26.9% | 239,500 | -9.7% | 0.01% | -22.2% |
| Q3 2016 | $5,458,000 | -36.8% | 265,200 | -6.1% | 0.01% | -35.7% |
| Q2 2016 | $8,641,000 | -20.6% | 282,400 | -2.9% | 0.01% | -22.2% |
| Q1 2016 | $10,885,000 | -18.0% | 290,800 | -5.5% | 0.02% | -14.3% |
| Q4 2015 | $13,276,000 | +20.4% | 307,600 | +4.6% | 0.02% | +10.5% |
| Q3 2015 | $11,027,000 | +10.3% | 294,200 | 0.0% | 0.02% | +26.7% |
| Q2 2015 | $10,000,000 | -13.3% | 294,200 | -3.4% | 0.02% | -6.2% |
| Q1 2015 | $11,535,000 | 0.0% | 304,600 | 0.0% | 0.02% | 0.0% |
| Q4 2014 | $11,535,000 | +1.7% | 304,600 | +3.5% | 0.02% | 0.0% |
| Q3 2014 | $11,347,000 | -44.4% | 294,200 | -43.9% | 0.02% | -42.9% |
| Q2 2014 | $20,411,000 | -14.6% | 524,430 | -11.4% | 0.03% | -17.6% |
| Q1 2014 | $23,896,000 | +74.7% | 591,640 | +4.6% | 0.03% | +70.0% |
| Q4 2013 | $13,677,000 | +130.1% | 565,400 | +123.5% | 0.02% | +81.8% |
| Q3 2013 | $5,944,000 | -0.2% | 252,952 | +14.2% | 0.01% | -8.3% |
| Q2 2013 | $5,953,000 | – | 221,552 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |